Résumé
Le syndrome de l’intestin irritable (SII) au sens strict touche environ 5 % de la population françise, mais prés de 70 % des sujets adultes se plaignent de symptômes digestifs fréquents. Le SII est á l’origine de coûts directs modérés (72 á 1 590 € par an et par patient), probablement sous-estimés, mais qui finissent par représenter une dépense de santé importante compte tenu de la fréquence de la maladie et de son caracte`re chronique et récurrent. Les coûts indirects sont mal connus et sans doute plus importants compte tenu du retentissement du SII sur la qualité de vie.
Abstract
Five percent of the French population suffer from true irritable bowel syndrome but almost 70% of adults complain of frequent digestive problems. IBS generates moderate direct costs per subject (72 to 1 590 € a year), which is more than likely an underestimate, but this is a significant health cost considering the frequency of the disease and its chronic and recurrent nature. Indirect costs are difficult to assess but are certainly significant considering the impact of irritable bowel syndrome on quality of life.
Références
Amouretti M, Le Pen C, Gaudin AF, et al. (2006) Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol; 30: 241–246
El-Serag HB, Olden K, Bjorkman D (2002) Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 16: 1171–1185
Gralnek IM, Hays RD, Kilbourne A, et al. (2000) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119: 654–660
Bommelaer G, Poynard T, Le Pen C, et al. (2004) Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 28: 554–561
Dapoigny M, Bellanger J, Bonaz B, et al. (2004) Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 16: 995–1001
Hungin AP, Whorwell PJ, Tack J, et al. (2003) The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 17: 643–650
Frexinos J, Denis P, Allemand H, et al. (1998) É tude descriptive des symptômes fonctionnels digestifs au sein de la population françise. Gastroenterol Clin Biol 22: 785–791
Le Pen C, Ruszniewski P, Gaudin AF, et al. (2004) The burden cost of French patients suffering from irritable bowel syndrome. Scand J Gastroenterol 39: 336–343
Bentkover JD, Field C, Geene E, et al. (1999) The economic burden of irritable bowel syndrome in Canada. Can J Gastroenterol 13Suppl A: 89A–96A
Creed F, Ratcliffe J, Fernandez L, et al. (2001) Healthrelated quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 134,9 Pt 2: 860–868
Danchequin Dorval E, Delvaux M, et al. (1994) Profil et évolution du syndrome de l’intestin irritable: étude épidémiologique nationale prospective chez 1301 consultants en gastroentérologie suivis 9 mois. Gastroenterol Clin Biol 18: 145–150
Dapoigny M, Dyard F, Grimaud JC, et al. (2003) Syndrome de l’intestin irritable et consommation de soins. Étude observationnelle en gastroentérologie. Gastroenterol Clin Biol 27: 265–271
Brun-Strang C, Dapoigny M, Lafuma A, et al. (2007) Irritable bowel syndrome in France: quality of life, medical management and costs: The ENCOLI study. Eur J Gastroenterol Hepatol
Coffin B, Dapoigny M, Cloarec D, et al. (2004) Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol Clin Biol 28: 11–15
Thompson WG, Longstreth GF, Drossman DA, et al. (1999) Functional bowel disorders and functional abdominal pain. Gut 45,Suppl 2: 43–47
Longstreth GF, Thompson WG, Chey WD, et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480–1491
Hasler WL, Schoenfeld P (2003) Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 17: 997–1005
Francis CY, Duffy JN, Whorwell PJ, et al. (1996) Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol 91:1348–1350
Muller-Lissner SA, Pirk O (2002) Irritable bowel syndrome in Germany. A cost of illness study. Eur J Gastroenterol Hepatol 14,12: 1325–1329
Cash B, Sullivan S, Barghout V (2005) Total costs of IBS: employer and managed care perspective. Am J Manag Care 11(1 Suppl): S7–16
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Dapoigny, M. Troubles fonctionnels intestinaux et impact en santé publique. Colon Rectum 1, 255–258 (2007). https://doi.org/10.1007/s11725-007-0063-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11725-007-0063-7